Evolent Health Non-GAAP EPS of $0.10 beats by $0.05, revenue of $319.9M beats by $22.06M
- Evolent Health press release (NYSE:EVH): Q2 Non-GAAP EPS of $0.10 beats by $0.05.
- Revenue of $319.9M (+44.0% Y/Y) beats by $22.06M.
- Revenue for the year ending December 31, 2022 is expected to be in the range of approximately $1.32 billion to $1.36 billion ($1.21B consensus). Adjusted EBITDA is expected to be in the range of approximately $95.0 million to $105.0 million.
Recommended For You
Comments (2)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.
ssatrams
02 Aug. 2022
I keep adding more to my long-term portfolio
A
Amstragram
02 Aug. 2022
This is taking off for good !